Share

Mexico participates in Walvax COVID-19 vaccine trials

Media Dec 7, 2021 adn40

Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.

Related Links

Walvax Shares Vaccine Development Expertise at 11th National Vaccine Conference of Thailand

Walvax Publishes Immunogenicity and Safety Data from Phase 3 Clinical Study of PCV13 (the 2nd available 13-valent pneumococcal polysaccharide conjugate vaccine worldwide) in Frontiers in Microbiology

Walvax Biotechnology Achieves ESG Rating Upgrade to BBB from MSCI